Related by context. All words. (Click for frequent words.) 73 hypoglycemia 72 severe hypoglycemic 71 hypoglycemic events 70 hypoglycaemia 70 hypoglycemic episodes 70 severe hypoglycaemia 68 reinfarction 67 VT VF 67 nocturnal hypoglycemia 67 nocturnal hypoglycaemia 67 hyperglycemia 66 extrapyramidal symptoms 66 decompensation 66 decompensated heart failure 66 hyperkalemia 65 left ventricular dysfunction 65 insulin detemir 65 hyperglycaemia 65 cerebrovascular events 65 thromboembolism 65 thromboembolic events 65 renal insufficiency 65 recurrent VTE 65 β blockers 65 hypoglycaemic 64 periprocedural 64 EXJADE 64 severe exacerbations 64 lactic acidosis 64 recurrent ischemia 64 arterial thromboembolic events 64 thrombotic events 64 hypoglycaemic episodes 64 TEAEs 63 salmeterol HFA MDI 63 postoperative AF 63 T2DM 63 GERD symptoms 63 variceal bleeding 63 renal dysfunction 63 HbA1c levels 63 nonfatal MI 63 tachyarrhythmias 63 thromboembolic 63 ventricular arrhythmia 63 hemorrhagic complications 62 plasma glucose levels 62 vertebral fracture 62 colorectal adenoma 62 TNF antagonist 62 Hypotension 62 macrovascular events 62 comorbid conditions 62 proliferative diabetic retinopathy 62 hematologic toxicity 62 polyp recurrence 62 subcutaneous insulin 62 NPH insulin 62 systolic hypertension 62 ipsilateral stroke 62 sustained ventricular tachycardia 62 subclinical hypothyroidism 62 corticosteroid therapy 62 hepatotoxicity 62 Severe hypoglycemia 62 ALT flares 62 nocturnal awakenings 62 intracerebral hemorrhage 62 virologic failure 62 transaminase elevations 62 glycated hemoglobin levels 61 lipid abnormalities 61 glycemia 61 paroxysmal AF 61 microalbuminuria 61 acute decompensation 61 reflux symptoms 61 NYHA class 61 Hypoglycemia 61 prolonged QT interval 61 gout flares 61 nonadherence 61 metabolic acidosis 61 hemoglobin A1c levels 61 elevated ALT 61 ventricular fibrillation VF 61 RLS symptoms 61 antihypertensive therapy 61 platelet reactivity 61 Erythropoietic therapies may 61 depressive symptoms 61 ventricular tachycardia VT 61 dopaminergic therapy 61 recurrent atrial fibrillation 61 ventricular tachyarrhythmia 61 incontinence episodes 61 NATRECOR R 61 TMP SMX 61 myocardial infarction 61 APTIVUS r 61 hypotension 61 revascularizations 61 virological failure 61 syncope 61 baseline HbA1c 61 lispro 61 adrenal insufficiency 61 cardiovascular mortality 61 QTc intervals 61 ventricular arrhythmias 61 hypocalcemia 61 LVSD 61 EDSS scores 61 coadministration 60 elevated creatinine 60 intracerebral haemorrhage 60 hypokalemia 60 hypercalcemia 60 rimonabant #mg 60 HbA 1c levels 60 amenorrhea 60 torsades de pointes 60 nondiabetic patients 60 aripiprazole 60 MULTAQ 60 elevated uric acid 60 hypoxemia 60 atherogenic dyslipidemia 60 recurrent venous thromboembolism 60 tumor lysis syndrome 60 laboratory abnormalities 60 prodromal symptoms 60 rebleeding 60 adjunctive ABILIFY 60 virologic breakthrough 60 repeat revascularization 60 contrast induced nephropathy 60 T1DM 60 fragility fracture 60 severe neutropenia 60 plasma glucose 60 myocardial infarctions 60 postoperative morbidity 60 venous thrombosis 60 ventricular tachycardia 60 macrovascular disease 60 Febrile neutropenia 60 generalized seizures 60 antihypertensive medications 60 hemodilution 60 severe hypersensitivity reactions 60 parkinsonian symptoms 60 systolic dysfunction 60 acromegalic patients 60 macrovascular 60 VIIBRYD 60 lipid lowering therapy 60 multivariate adjustment 60 refractory ischemia 60 asthma exacerbations 60 ventricular tachyarrhythmias 60 lamotrigine 60 asthma exacerbation 60 untreated OSA 60 Thrombotic events 60 systolic BP 60 fibrinolysis 60 hypoglycemic 60 hyperammonemia 60 prednisone prednisolone 60 akathisia 59 virological response 59 neurologic sequelae 59 unfractionated heparin 59 upper gastrointestinal bleeding 59 VADT 59 fasting plasma glucose 59 serum urate 59 Suicidal ideation 59 hemoglobin A1c HbA1c 59 postprocedure 59 overt HE 59 binary restenosis 59 OADs 59 hypophosphatemia 59 QT prolongation 59 neuroleptics 59 triglyceride concentrations 59 postoperative mortality 59 leucopenia 59 elevated triglyceride levels 59 QTc prolongation 59 intensive statin therapy 59 Infusion Reactions Severe 59 cytopenias 59 stable angina 59 PSADT 59 syncopal episode 59 induce orthostatic hypotension 59 impaired fasting glucose 59 oxygen desaturation 59 myopathy rhabdomyolysis 59 overt nephropathy 59 angina chest 59 syncope fainting 59 apneic 59 PREZISTA r 59 hyperbilirubinemia 59 lowering blood glucose 59 coronary stenosis 59 lipid lowering agents 59 paclitaxel eluting stents 59 beta blocker therapy 59 perioperative complications 59 ATACAND 59 gouty arthritis 59 hypoglycemia unawareness 59 aminotransferases 59 elevated LDL cholesterol 59 ICD shocks 59 pathologic fractures 59 aldosterone antagonists 59 antiarrhythmic drugs 59 orthostatic hypotension 59 lipid lowering medications 59 intracranial bleeding 59 QT interval prolongation 59 nephrotoxicity 59 postoperative complication 59 rFVIIa 59 vigorous exertion 59 hepatic dysfunction 59 definite stent thrombosis 59 inhospital 59 morphometric vertebral fractures 59 myocardial infarction MI 58 dysglycemia 58 octreotide LAR 58 coronary revascularization 58 Postoperative complications 58 renal toxicity 58 vasovagal syncope 58 angiographic outcomes 58 CVD mortality 58 depressive symptomatology 58 daytime drowsiness 58 clinically meaningful reductions 58 renal impairment 58 serum creatinine levels 58 subclinical hyperthyroidism 58 HbA 1c 58 postprandial glucose 58 hypopneas 58 venlafaxine Effexor 58 fluid overload 58 glycated hemoglobin HbA1c 58 % CI #.#-#.# [006] 58 Stent thrombosis 58 exacerbations 58 symptomatic VTE 58 alanine aminotransferase 58 detemir 58 postoperative delirium 58 eplerenone 58 serum phosphate 58 unstable angina pectoris 58 apnea hypopnea 58 A1c levels 58 concomitant antibiotics 58 corticosteroid dose 58 nonsignificant 58 TZDs 58 elevated serum creatinine 58 impaired renal 58 insulin glargine 58 adjunctive placebo 58 bronchopulmonary dysplasia 58 analgesic medications 58 nighttime awakenings 58 intracranial hemorrhage ICH 58 prolactin elevation 58 neuropsychiatric symptoms 58 tolvaptan 58 LV dysfunction 58 heparin induced thrombocytopenia 58 asymptomatic PAD 58 cardiovascular hospitalization 58 risperidone Risperdal 58 hypomagnesemia 58 neurodevelopmental impairment 58 VAPRISOL 58 febrile neutropenia 58 fatal myocardial infarction 58 MMSE scores 58 serum uric acid 58 cerebrovascular accident 58 elevated troponin 58 symptom exacerbation 58 β blocker 58 endometrial hyperplasia 58 tachyarrhythmia 58 hypertensive patients 58 ADHF 58 revascularization procedures 58 diabetes mellitus 58 acute myocardial infarction AMI 58 CrCl 58 paricalcitol 58 URTI 58 arrhythmias 58 severe renal impairment 58 hypersomnia 58 syncopal 58 oral corticosteroids 58 OGTT 58 clomipramine 58 aneurysmal subarachnoid hemorrhage 58 atypical antipsychotic medications 58 noncardiovascular mortality 58 diastolic hypertension 58 asymptomatic AF 58 tHcy 58 concomitant medications 58 thrombotic complications 58 thyrotoxicosis 58 cardiac toxicity 58 advanced adenomas 58 hepatic function 58 pramlintide 58 MetS 58 cardiac dysfunction 58 intermittent claudication 58 colorectal adenomas 58 oral antidiabetic agents 58 nontraumatic 58 constipation nausea 58 nonvertebral fractures 58 acute renal failure 58 receiving VELCADE 58 hypomanic episodes 58 rehospitalization 58 CMV infection 58 cirrhotic patients 58 biphasic insulin aspart 58 Torsades de Pointes 58 PONV 58 ICD implantation 58 serum calcium 58 CLA supplementation 58 MS relapses 58 hypotensive 58 glycemic control 58 quetiapine 58 pulmonary dysfunction 58 acute gout flares 58 serum potassium 58 hypovolemia 58 recurrent UTI 57 PGTC seizures 57 NYHA Class II 57 dapagliflozin plus 57 #mg/day [001] 57 carotid stenosis 57 Hypoglycaemia 57 bolus dose 57 primidone 57 serum calcium levels 57 CK MB 57 systemic corticosteroids 57 antiplatelet drugs 57 metformin accumulation 57 serum urate levels 57 psoriatic arthritis PsA 57 REYATAZ r arm 57 serum triglyceride levels 57 CI #.#-#.# [001] 57 OAB symptoms 57 fasting insulin 57 haemorrhagic stroke 57 intravenous bisphosphonates 57 silent ischemia 57 A1C levels 57 cerebral infarction 57 ocular adverse 57 kidney dysfunction 57 autoimmune reactions 57 Lactic acidosis 57 albuminuria 57 sulphonylureas 57 recurrent DVT 57 hypoglycemic coma 57 vertebral fractures 57 fasting glucose levels 57 myocardial infarction stroke 57 apneas 57 extrapyramidal side 57 Pioglitazone 57 glycosylated hemoglobin HbA1c 57 neurologic dysfunction 57 atrial fibrillation AF 57 urate lowering therapy 57 PRADAXA 57 autonomic dysfunction 57 thromboembolic complications 57 status epilepticus 57 nephrotoxic 57 hematologic adverse 57 proteinuria 57 torsade de pointes 57 ischemic complications 57 paroxetine Paxil 57 microvascular complications 57 infusion reactions 57 olanzapine 57 alcoholic cirrhosis 57 adrenal suppression 57 impaired cognition 57 oral antidiabetic drugs 57 plasma triglycerides 57 gross hematuria 57 nonfatal stroke 57 macroalbuminuria 57 bradycardia 57 lacosamide 57 EFFEXOR XR 57 PSA nadir 57 coronary revascularization procedures 57 nicardipine 57 inhaled budesonide 57 MACCE 57 vasospasm 57 postoperative atrial fibrillation 57 pulmonary exacerbation 57 NNT = 57 RLAI 57 androgen suppression 57 Clinically significant 57 NovoLog ® Mix 57 asymptomatic carotid stenosis 57 Thrombocytopenia 57 tapentadol ER 57 HBeAg positive patients 57 leukopenia 57 platelet inhibition 57 glucose lowering 57 DMARD 57 intravascular hemolysis 57 adenoma recurrence 57 infarctions 57 induced hypoglycemia 57 DLTs 57 COPD exacerbations 57 transferrin saturation 57 serum phosphorus 57 infarct size 57 atrial fibrillation 57 primary hypercholesterolemia 57 bone marrow suppression 57 cerebral vasospasm 57 untreated sleep apnea 57 acarbose 57 GH deficiency 57 DMARD therapy 57 hepatic encephalopathy 57 serum IGF 57 somatic symptoms 57 FOLFOX4 57 symptomatic pulmonary embolism 57 dexmedetomidine 57 Fasting plasma glucose 57 extubation 57 antiretroviral naive 57 cardiac autonomic 57 fasting triglycerides 57 moderate renal impairment 57 NAFLD 57 overactive bladder symptoms 57 elevated lipase 57 glitazones 57 myelosuppression 57 glomerular filtration 57 blood Phe levels 57 non aspirin NSAIDs 57 neurologic complications 57 comorbidities 57 receiving APTIVUS r 57 comorbid depression 57 proximal DVT 57 advanced adenoma 57 neurologic symptoms 57 bezafibrate 57 venous thromboembolic events 57 cardiovascular ischemic 57 antithrombotic therapy 57 electrical cardioversion 57 uncontrolled epilepsy 57 delayed gastric emptying 57 oral antidiabetic medication 57 conventional antipsychotics 57 placebo p = 57 hyperinsulinemia 56 haematologic 56 ACTOplus met XR 56 tardive dyskinesia 56 atrophic gastritis 56 MAOIs 56 + PH# 56 unexplained fainting 56 hyperprolactinemia 56 desvenlafaxine succinate 56 anakinra 56 prolactin levels 56 mg kg dose 56 cardiogenic shock 56 fluoxetine Prozac 56 androgen deprivation 56 confidence interval #.#-#.# 56 pulmonary exacerbations 56 symptomatic hyponatremia 56 anaphylactoid reactions 56 oral antidiabetes 56 insulin lispro 56 ropivacaine 56 AA Amyloidosis 56 intermittent hypoxia 56 hypercholesterolaemia 56 elevated bilirubin 56 SRBD 56 atherothrombotic events 56 neutropaenia 56 triglyceride concentration 56 preserved ejection fraction 56 Topiramate 56 systemic corticosteroid 56 obstructive apnea 56 endometrial thickness 56 prescribed beta blocker 56 lowest tertile 56 IOP lowering 56 prescribed opioids 56 LANTUS ® 56 nonvertebral fracture 56 umol L 56 deferiprone 56 acute coronary syndromes ACS 56 severe hypoglycemic episodes 56 post thrombotic syndrome 56 amenorrhoea 56 potassium sparing diuretics 56 acute coronary 56 rhythm disturbances 56 Excessive daytime sleepiness 56 nonfasting triglyceride levels 56 depressive symptom 56 alcoholic fatty liver 56 anemia neutropenia 56 solifenacin 56 leukotriene receptor antagonists 56 hemodynamic instability 56 lopinavir r arm 56 serum sodium 56 renal artery stenosis 56 treatment emergent AEs 56 progressive PsA 56 % CI #.#-#.# [007] 56 RBP4 levels 56 impaired hepatic 56 serum aminotransferase levels 56 HF hospitalization 56 ruboxistaurin 56 monoamine oxidase inhibitors 56 polypharmacy 56 thrombocytopenia 56 CIMZIA ™ 56 postoperative nausea 56 recurrent myocardial infarction 56 abdominal adiposity 56 onset atrial fibrillation 56 postoperative infections 56 comorbid disorders 56 anastomotic leak 56 NovoMix ® 56 haloperidol Haldol 56 angiographic restenosis 56 tiotropium 56 hepatic impairment 56 Exacerbations 56 COPD exacerbation 56 esophagitis 56 serum phosphorous 56 glipizide 56 NATRECOR ® 56 myocardial reperfusion 56 cranial irradiation 56 aspartate aminotransferase AST 56 aldosterone antagonist therapy 56 recurrent wheezing 56 neutropenic patients 56 left ventricular systolic 56 HPA axis suppression 56 hyperoxaluria 56 serum phosphate levels 56 hepatic cirrhosis 56 proliferative retinopathy 56 discontinuations due 56 unstable angina UA 56 uncontrolled asthma 56 urinary symptoms 56 recurrent ischemic 56 cardiovascular morbidity 56 lipid parameters 56 serum potassium levels 56 macrovascular complications 56 glargine 56 Apidra ® 56 diabetic gastroparesis 56 hemorrhagic cystitis 56 nondiabetics 56 thiazide diuretic 56 serum triglycerides 56 hepatorenal syndrome 56 AGILECT ® 56 MADRS score 56 elevated blood glucose 56 colorectal neoplasia 56 Hepatotoxicity 56 LVEF 56 Victoza R 56 suicidal ideation 56 co morbidities 56 anticonvulsant medications 56 nonfatal myocardial infarction MI 56 nonobese 56 metformin sulphonylurea 56 sotalol 56 loop diuretics 56 myocardial ischemia 56 benazepril 56 mixed hyperlipidemia 56 bronchospasm 56 ALT elevations 56 invasive aspergillosis 56 ximelagatran 56 achieved ACR# 56 unresectable HCC 56 serum estradiol 56 mild renal insufficiency 56 virologic response 56 INVEGA ® 56 hypertension diabetes mellitus 56 hyperglycaemic 56 NIASPAN 56 dysmenorrhoea 56 lipid lowering drugs 56 postsurgical complications 56 hepatic toxicity 56 â ‰ ¥ 56 ACEI ARB 56 stent thromboses 56 tegaserod 56 postintervention 56 typical antipsychotics 56 treatment emergent adverse 56 hypoperfusion 56 hereditary antithrombin deficiency 56 ischemic stroke 56 adenoidectomy 56 hyperalgesia 56 gout flare 56 ziconotide 56 ACE inhibitor ramipril 56 anticholinergic medications 56 MMSE score 56 adenotonsillectomy 56 salmeterol fluticasone 56 XIENCE V demonstrated 56 urinary retention 56 anticoagulation 56 cardiac tamponade 56 pericardial effusion 56 MIRAPEX 56 atrial arrhythmias 56 elevated triglycerides 56 atypical fractures 56 oral hypoglycemic agents 56 tapentadol IR 56 postoperative complications 56 levodopa therapy 56 noncardiac 56 resynchronization therapy 56 isolated systolic hypertension 55 Exclusion criteria 55 urinary leakage 55 nondepressed 55 spontaneous preterm birth 55 gastrointestinal perforation 55 LATUDA 55 annualized relapse 55 neurocognitive deficits 55 chronic GVHD 55 antiarrhythmic drug 55 interstitial pneumonia 55 neutrophil counts 55 venous blood clots 55 transaminase levels 55 EBRT 55 p = .# [002] 55 microvascular disease 55 improves glycemic 55 HbA1C levels 55 acute urinary retention 55 oxcarbazepine 55 unfavorable cytogenetics 55 hypertension 55 bosentan 55 juvenile idiopathic arthritis JIA 55 mcg kg REBETOL 55 antiepileptic medications 55 flutamide 55 rufinamide 55 creatinine clearance 55 de ath 55 non affective psychosis 55 QTc interval 55 symptomatic hypoglycemia 55 eculizumab therapy 55 hemoptysis 55 perioperative morbidity 55 deep venous thromboses 55 amiodarone 55 bronchodilation 55 adiponectin levels 55 pCR 55 symptomatic hypotension 55 systemic hypotension 55 abnormal lipids 55 fasting triglyceride levels 55 landmark ATHENA trial 55 cardiac troponin 55 tirofiban 55 psychiatric comorbidities 55 ARCOXIA 55 impaired glucose metabolism 55 intravitreal injections 55 triglyceride levels 55 HDL C 55 intima media thickness 55 ARICEPT 55 necrotizing pancreatitis 55 ischemic cardiomyopathy 55 anaphylactic episodes 55 hypersensitivity reactions 55 eosinophilic asthma 55 ziprasidone Geodon 55 daytime sleepiness 55 basal insulin 55 CYP #A# 55 pyrexia mucositis sepsis febrile 55 hypopnea 55 p = NS 55 antihypertensive agents 55 dose colchicine 55 insulin secretagogue 55 gallstone disease 55 verapamil 55 peripheral sensory neuropathy 55 urinary albumin 55 failure ADHF 55 apnea hypopnea index 55 atrioventricular block 55 cognitive impairment 55 ticlopidine 55 DAPT 55 nesiritide 55 NNRTI resistance 55 opioid overdose 55 Paxil paroxetine 55 placebo p 55 gastrointestinal bleeds 55 distal colon cancer 55 ischemic cardiovascular 55 basal cell nevus syndrome 55 RISPERDAL ® 55 opioid analgesia 55 obstructive CAD 55 metformin 55 inhaled glucocorticoids 55 nonfatal myocardial infarction 55 MAO inhibitors 55 inadequate glycemic 55 noncardiovascular 55 #mmHg [001] 55 lipid levels 55 antiplatelet medications 55 anticholinergics 55 UA NSTEMI 55 glyburide 55 Navelbine ® 55 Depressive symptoms 55 cardiovascular hospitalizations 55 hypercholesterolemic patients 55 glucose tolerance test 55 receiving XGEVA 55 delayed CINV 55 antidiabetic medication 55 onset diabetes mellitus 55 recurrent glioblastoma multiforme 55 resuscitated cardiac arrest 55 magnesium intake 55 liver transaminases 55 anemia hemoglobin 55 ketoacidosis hyperosmolar coma 55 thioridazine 55 oxycodone CR 55 BYSTOLIC 55 carotid atherosclerosis 55 PRADAXA #mg 55 psychiatric hospitalization 55 Orthostatic hypotension 55 coronary blockages 55 CPAP adherence 55 gastrointestinal GI 55 dysfunction LVSD 55 neutropenia dehydration dyspnea 55 insulin sensitizing 55 dysthymia 55 intravenous diuretics 55 paroxysmal supraventricular tachycardia 55 hsCRP levels 55 sitagliptin 55 pentoxifylline 55 Tardive dyskinesia 55 canakinumab 55 antihypertensive medication 55 primary generalized tonic 55 thrombosis 55 P = .# 55 angiotensin II receptor blockers 55 hypercapnia 55 oral corticosteroid 55 trimethoprim sulfamethoxazole 55 flow mediated dilation 55 hemodynamically unstable 55 cardiovascular disease 55 receiving ISENTRESS 55 Hypocalcemia 55 reoperations 55 euthymic 55 dosage regimens 55 quetiapine Seroquel 55 FOSRENOL ® 55 diabetic ketoacidosis DKA 55 CI -#.# 55 acute GVHD 55 Acute renal failure 55 severe obstructive sleep 55 HBeAg negative patients 55 % CI #.#-#.# [003] 55 dalteparin 55 liver decompensation 55 thyrotropin levels 55 lipid lowering therapies 55 unmeasured confounders 55 vasomotor symptoms 55 clazosentan 55 protein excretion 55 neurodevelopmental outcome 55 perimenopausal women 55 #mmHg [002] 55 somnolence dizziness 55 alteplase 55 MIRAPEX ER 55 acute psychosis 55 HbA1c 55 gastric acidity 55 graft occlusion 55 pyelonephritis 55 chronic renal insufficiency 55 neuroleptic malignant syndrome 55 nonobstructive CAD 55 generalized tonic clonic seizures 55 pharmacological interventions 55 hyperphenylalaninemia HPA due 55 ACTOplus met 55 AGILECT R 55 thromboprophylaxis 55 lispro alone 55 serum cortisol 55 uncontrolled bleeding 55 subtrochanteric 55 lymphopenia 55 leukopenia pancytopenia thrombocytopenia 55 chronic periodontitis 55 carotid IMT 55 alpha interferons 55 gemifloxacin 55 divalproex 55 citalopram Celexa 55 hypertensives 55 undergoing CABG 55 urate levels 55 oral anticoagulation 55 glucose intolerance 55 dronedarone 55 antiplatelet medication 55 postoperative pulmonary 55 prostate cancer CaP 55 phenytoin 55 subclinical atherosclerosis 55 Chronic ITP 55 toxicities 55 zolmitriptan 55 citalopram 55 urate lowering 55 oral anticoagulant therapy 55 thrombolytic therapy 55 recurrent stroke 55 antidiabetic medications 55 coronary calcification 55 antidiabetic drug 55 TMC# r 55 malabsorptive 55 AZOR 55 chlorambucil 55 diabetes mellitus DM 55 valproate 55 hematologic toxicities 55 coagulopathy 55 methimazole 55 GnRH agonists 55 sinus tachycardia 55 vestibular dysfunction 55 noncardiac surgery 55 Toxicities 55 APIDRA R 55 headache nausea fatigue 55 HBeAg seroconversion 55 divalproex sodium 55 thiazolidinedione 55 anthracycline containing 55 ABILIFY 55 perioperatively 55 venlafaxine XR 55 postoperative hemorrhage 55 #.#/#.# mmHg [001] 55 GnRH agonist 55 ketoacidosis 55 acutely decompensated congestive heart 55 Contrast Induced Nephropathy CIN 55 perioperative mortality 55 thromboses 54 candidemia 54 serum cholesterol 54 venous thromboembolic disease 54 induced ischemia 54 ventilatory 54 thrombolytic agents 54 aldosterone antagonist 54 XIENCE V PROMUS Stent 54 serum glucose 54 mmol l 54 sertraline Zoloft 54 parasomnias 54 extrapyramidal symptoms EPS 54 blood glucose concentrations 54 nonoperative treatment 54 Hb A1C 54 hypocaloric diet 54 peri procedural 54 sedating antihistamine 54 onset sepsis 54 aminotransferase elevations greater 54 PREZISTA r arm 54 vomiting PONV 54 5-FU/LV 54 KETEK 54 fetal malformations 54 periprocedural MI 54 fluvastatin 54 recurrent acute pancreatitis 54 severe renal insufficiency 54 isoproterenol 54 CRBSI 54 cataract formation 54 strong CYP#A# inducers 54 electrolyte abnormalities 54 neurologic outcomes 54 neuroleptic 54 LANTUS R 54 ddI 54 metabolic disturbances 54 thiazide diuretics 54 metformin monotherapy 54 fatal IHD 54 antibiotic prophylaxis 54 ziprasidone 54 onset seizures 54 postural hypotension 54 thrombus aspiration